Wellington Management Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,272,054
| Closed | -$121M | – | 2177 |
|
|
2019
Q2 | $121M | Buy |
10,272,054
+112,972
| +1% | +$1.33M | 0.03% | 510 |
|
|
2019
Q1 | $139M | Buy |
10,159,082
+5,393,959
| +113% | +$73.6M | 0.03% | 464 |
|
|
2018
Q4 | $48.8M | Buy |
4,765,123
+624,954
| +15% | +$6.41M | 0.01% | 714 |
|
|
2018
Q3 | $68.9M | Sell |
4,140,169
-759,786
| -16% | -$12.7M | 0.01% | 696 |
|
|
2018
Q2 | $77.4M | Sell |
4,899,955
-88,523
| -2% | -$1.4M | 0.02% | 661 |
|
|
2018
Q1 | $63.4M | Buy |
4,988,478
+473,385
| +10% | +$6.01M | 0.01% | 710 |
|
|
2017
Q4 | $51.7M | Sell |
4,515,093
-397,777
| -8% | -$4.55M | 0.01% | 762 |
|
|
2017
Q3 | $60.2M | Buy |
4,912,870
+1,315,639
| +37% | +$16.1M | 0.01% | 694 |
|
|
2017
Q2 | $41.2M | Sell |
3,597,231
-43,557
| -1% | -$499K | 0.01% | 792 |
|
|
2017
Q1 | $75.7M | Buy |
3,640,788
+26,791
| +0.7% | +$557K | 0.02% | 593 |
|
|
2016
Q4 | $75.2M | Sell |
3,613,997
-222,275
| -6% | -$4.62M | 0.02% | 594 |
|
|
2016
Q3 | $126M | Sell |
3,836,272
-543,691
| -12% | -$17.8M | 0.03% | 418 |
|
|
2016
Q2 | $109M | Buy |
4,379,963
+1,223,098
| +39% | +$30.5M | 0.03% | 453 |
|
|
2016
Q1 | $77.3M | Buy |
3,156,865
+1,803,110
| +133% | +$44.2M | 0.02% | 544 |
|
|
2015
Q4 | $44.7M | Buy |
1,353,755
+1,314,206
| +3,323% | +$43.4M | 0.01% | 704 |
|
|
2015
Q3 | $1.3M | Sell |
39,549
-5,620
| -12% | -$184K | ﹤0.01% | 1765 |
|
|
2015
Q2 | $2.39M | Sell |
45,169
-183,000
| -80% | -$9.7M | ﹤0.01% | 1616 |
|
|
2015
Q1 | $6.59M | Sell |
228,169
-80,020
| -26% | -$2.31M | ﹤0.01% | 1363 |
|
|
2014
Q4 | $8.97M | Buy |
308,189
+65,770
| +27% | +$1.91M | ﹤0.01% | 1279 |
|
|
2014
Q3 | $3.07M | Buy |
242,419
+87,500
| +56% | +$1.11M | ﹤0.01% | 1575 |
|
|
2014
Q2 | $3.11M | Buy |
+154,919
| New | +$3.11M | ﹤0.01% | 1576 |
|